Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,435.00
Bid: 1,454.00
Ask: 1,456.00
Change: -5.00 (-0.35%)
Spread: 2.00 (0.138%)
Open: 1,440.00
High: 1,474.00
Low: 1,435.00
Prev. Close: 1,440.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Gain After Powell Remarks; Indivior Surges

Thu, 11th Jul 2019 08:36

(Alliance News) - London stocks on Thursday started the second day of US Federal Reserve Chair Jerome Powell's testimony to Congress in positive territory after dovish remarks made on Wednesday.Reckitt Benckiser was among the stocks pushing the FTSE 100 higher after agreeing to settle a US probe for USD1.4 billion, while former subsidiary Indivior surged on boosted guidance.The large-cap index was 19.88 points higher, or 0.3%, at 7,550.57 early Thursday. The mid-cap FTSE 250 index was up 77.01 points, or 0.4%, at 19,496.39, while the AIM All-Share was flat at 914.43.The Cboe UK 100 index was up 0.2% at 12,800.40. The Cboe UK 250 was 0.3% higher at 17,387.03, while the Cboe UK Small Companies was up 0.7% at 11,313.55.In mainland Europe, the CAC 40 index in Paris and DAX 30 in Frankfurt were up 0.3% and 0.2% respectively in early trade.Stocks in Europe started Thursday's session on the front foot after dovish remarks from US Federal Reserve Chair Jerome Powell. In comments welcomed by Wall Street, Powell said many central bankers believed the case for lower rates "had strengthened" last month given the rising "crosscurrents" in the economy.In his highly anticipated testimony to Congress, Powell repeatedly stressed the importance of keeping the US economy growing to ensure its benefits reach Americans left at the margins and said the central bank will deploy all its tools to support continued expansion."Willingness to cut the [federal funds rate] removed the latest concerns of the most cautious market participants and launched a new round of rally, affecting a wide range of instruments - from the dollar and stock indexes to commodities," said analysts at FxPro.This positive sentiment in stock markets flowed through to Asia on Thursday, with the Japanese Nikkei 225 index ending up 0.5%. In China, the Shanghai Composite closed up 0.1%, while the Hang Seng index in Hong Kong is 0.7% higher in late trade.The day ahead has US inflation readings at 1330 BST. In addition, the Bank of England will release its financial stability report at 1030 BST, the European Central Bank releases accounts from its last monetary policy meeting at 1230 BST and Powell returns to Congress at 1500 BST. Already released, German inflation accelerated in June, as initially estimated, on higher package holiday prices.The consumer price index rose 1.6% year-on-year in June, reaffirming the provisional reading and faster than the 1.4% rise recorded for May. Month-on-month, consumer prices were up 0.3%, again in line with the flash reading.The higher inflation rate in June was caused by package holidays, Destatis said, with prices up 6.1% in June after a 9.0% fall in May. This helped to offset energy product prices rising just 2.5% in June, slowing from a 4.2% rise in May.In London, Reckitt was up 2.3% after agreeing to pay up to USD1.4 billion to resolve an investigation into the sales and marketing of Suboxone Film.Suboxone Film contains buprenorphine, a controlled substance that is used an an opioid replacement for addicts.The agreement has been reached with the US Department of Justice and the Federal Trade Commission. Suboxone Film is a product owned by Indivior, Reckitt's former prescription pharmaceuticals business which was demerged from the Reckitt group in 2014. Indivior now is separately listed on the London Stock Exchange.The payment will fully resolve all federal investigations into Reckitt in connection to Indivior's indictment and claims relating to state Medicaid programs for those states choosing to participate in the settlement."While RB has acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct, after careful consideration, the board of RB determined that the agreement is in the best interests of the company and its shareholders," said Reckitt.The company continued: "It avoids the costs, uncertainty and distraction associated with continued investigations, litigation and the potential for an indictment at a time of significant transformation under RB 2.0 and during CEO transition."Nurofen painkiller maker Reckitt currently has a provision of USD400 million which it will increase to USD1.5 billion at its half-year results.Separately, Indivior on Thursday raised its guidance following a stronger than expected first half.Indivior - which did not mention the Reckitt announcement in its own on Thursday - now expects net revenue in a range of USD670 million to USD720 million, a sharp increase from previous forecasts of USD525 million to USD575 million. Net income is expected between USD80 million to USD130 million. Prior to this, the company had anticipated anything from a loss of USD40 million to income of USD10 million.The primary driver has been a market share outperformance from Suboxone Film, the company explained. Indivior shot up 23% in early dealings.Credit checking firm Experian was towards the bottom of the FTSE 100 index, down 1.3% after Goldman Sachs cut the stock to Neutral from Buy.FTSE 250 technical products and services firm Diploma was up 2.8% after agreeing the GBP56.0 million takeover of a gasket and fluid-sealing products maker.Virginia Sealing Products specialises in customers who process and transport hazardous materials but also operates in markets such as power generation, pulp & paper, and marine. Diploma is paying GBP56.0 million in cash upfront, but it may also pay a further GBP8.0 million if VSP meets various operating profit targets. The deal will be funded from existing cash and new debt, but Diploma said it "will continue to maintain a strong balance sheet".

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

Friday 3 May 
Ashoka India Equity Investment Trust PLCGM re share issue
HSBC Holdings PLCAGM
Intercontinental Hotels Group PLCAGM
Mondi PLCAGM
More Acquisitions PLCAGM
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Caledonia Mining Corp PLCAGM
CPPGroup PLCAGM
Just Group PLCAGM
Macfarlane Group PLC AGM
Plus500 LtdAGM
Supernova Digital Assets PLCAGM
Wednesday 8 May 
Airea PLCAGM
Antofagasta PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Deltex Medical Group PLCAGM
Direct Line Insurance Group PLCAGM
Fidelity European Trust PLCAGM
Haleon PLCAGM
Jardine Matheson PLCAGM
JZ Capital Partners LtdEGM re investing in a secondary fund
Oscillate PLCAGM
Pershing Square Holdings LtdAGM
Rentokil Initial PLCAGM
WPP PLCAGM
Thursday 9 May 
Ascential PLCAGM
BAE Systems PLCAGM
Balfour Beatty PLCAGM
Barclays PLCAGM
CAB Payments Holdings PLCAGM
Catenai PLCGM re convertible loan note
Clarkson PLCAGM
FBD Holdings PLCAGM
Genel Energy plcAGM
Gym Group PLCAGM
Harbour Energy PLCAGM
Hiscox LtdAGM
IMI PLCAGM
Inchcape PLCAGM
Indivior PLCAGM
John Wood Group PLCAGM
Jupiter Fund Management PLCAGM
Logistics Development Group PLCAGM
Man Group PLCAGM
Morgan Advanced Materials PLCAGM
OSB Group PLCAGM
Public Policy Holding Co IncAGM
Rathbones Group PLCAGM
RM PLCAGM
Spire Healthcare Group PLCAGM
Synthomer PLCAGM
Uniphar PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York.

Read more
25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed its intention to shift its primary listing to the United States.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares.

Read more
12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
8 Mar 2024 20:04

IN BRIEF: Indivior chief commercial officer sells GBP500,000 in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600.

Read more
7 Mar 2024 12:39

DIRECTOR DEALINGS: Oxford Nanopore Technologies top team buys shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 19:10

Indivior says US court draws line on multi-district Suboxone case

(Alliance News) - Indivior PLC on Thursday said it received final court approval for a settlement of a multi-district Suboxone litigation case.

Read more
29 Feb 2024 09:47

Indivior receives settlement approval for antitrust litigation

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.

Read more
22 Feb 2024 16:53

LONDON MARKET CLOSE: European stocks boosted by ECB and Fed minutes

(Alliance News) - Stock prices in Europe closed higher on Thursday, on the back of minutes from the latest European Central Bank and US Federal Reserve meetings.

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.